Sls Pharmaceuticals Private Limited, a struck off private limited company, was established on 28 May 2013 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the manufacturing sector, it holds CIN: U24232TG2013PTC087974. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Nudurumati Naga Siva Kumar (Director), Tangirala Murali Kumar (Director), Satya Srinivas Mulukutla (Managing Director). Past directors included Nudurumati Naga Siva Kumar, Naga Raja Veera Bhadra Sarma Venkata Cherukuri, Vishnuvardhana Rao Yeleswarpu. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Plot No.25(A) H.No.6-273/2D,Near To Nalanda School Road No. 2 Indra Singh Nagar,, Hyderabad, Telangana, 500055.
U24232TG2013PTC087974
087974
28 May 2013
₹5.00 M
₹2.00 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Sls Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nudurumati Naga Siva Kumar | Director | 23 May 2015 | Current |
| Tangirala Murali Kumar | Director | 10 May 2014 | Current |
| Satya Srinivas Mulukutla | Managing Director | 28 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2015 | Past |
| Pramod Abcsdd | Director | 23 May 2015 | Past |
| Pramod Abcsdd | Director | 13 Jun 2016 | Past |
| Pramod Abcsdd | Director | 11 Jan 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 10 May 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sls Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 1025.87% increase. The company also saw a substantial improvement in profitability, with a 222.38% increase in profit. The company's net worth Soared by an impressive increase of 167.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Sls Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sls Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sls Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sls Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sls Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was recorded as a recent event.
Sls Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was recorded as a recent event.
The activity Nudurumati Naga Siva Kumar was appointed as a Director was appointed as a Director on 23 May 2015 & has been associated with this company since 10 years 7 months . was completed.
Progress on Tangirala Murali Kumar was appointed as a Director was appointed as a Director on 10 May 2014 & has been associated with this company since 11 years 7 months . was documented.
Progress on Satya Srinivas Mulukutla was appointed as a Managing Director was appointed as a Managing Director on 28 May 2013 & has been associated with this company since 12 years 6 months . was documented.
Sls Pharmaceuticals Private Limited was registered on 28 May 2013 with Roc Hyderabad & aged 12 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Sls Pharmaceuticals Private Limited is U24232TG2013PTC087974.
Sls Pharmaceuticals Private Limited is headquartered at Plot No.25(A) H.No.6-273/2D,Near To Nalanda School Road No. 2 Indra Singh Nagar,, Hyderabad, Telangana, 500055.
Sls Pharmaceuticals Private Limited was incorporated on 28 May 2013.
The current directors of Sls Pharmaceuticals Private Limited are
The primary industry of Sls Pharmaceuticals Private Limited is Manufacturing.
Sls Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sls Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Sls Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX